We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
- Authors
Kandratavicius, Ludmyla; Alves Balista, Priscila; Wolf, Daniele Cristina; Abrao, Joao; Evora, Paulo Roberto; Rodrigues, Alfredo Jose; Chaves, Cristiano; Maia-de-Oliveira, Joao Paulo; Pereira Leite, Joao; Murat Dursun, Serdar; Baker, Glen Bryan; Silveira Guimaraes, Francisco; Hallak, Jaime Eduardo Cecilio
- Abstract
Background: Better treatments for schizophrenia are urgently needed. The therapeutic use of the nitric oxide (NO)-donor sodium nitroprusside (SNP) in patients with schizophrenia has shown promising results. The role of NO in schizophrenia is still unclear, and NO modulation is unexplored in ketamine (KET) animal models to date. In the present study, we compared the behavioral effects of pre- and post-treatment with SNP, glyceryl trinitrate (GTN), andmethylene blue (MB) in the acute KET animal model of schizophrenia. The present study was designed to test whether acute SNP, GTN, and MB treatment taken after (therapeutic effect) or before (preventive effect) a single KET injection would influence the behavior of rats in the sucrose preference test, object recognition task and open field. Results: The results showed that KET induced cognitive deficits and hyperlocomotion. Long- term memory improvement was seen with the therapeutic GTN and SNP treatment, but not with the preventive one. MB pretreatment resulted in long-term memory recovery. GTN pre-, but not post-treatment, tended to increase vertical and horizontal activity in the KET model. Therapeutic and preventive SNP treatment consistently decreased KET-induced hyperlocomotion. Conclusion: NO donors - especially SNP - are promising new pharmacological candidates in the treatment of schizophrenia. In addition, we showed that the potential impact of NO-related compounds on KET-induced behavioral changes may depend on the temporal window of drug administration.
- Subjects
SODIUM nitroferricyanide; NITROGLYCERIN; METHYLENE blue; KETAMINE; SCHIZOPHRENIA
- Publication
BMC Neuroscience, 2015, Vol 16, Issue 1, p1
- ISSN
1471-2202
- Publication type
Article
- DOI
10.1186/s12868-015-0149-3